Biliary sludge and gallstone disease: actual scientific and practical aspects

Author: Vladimir Vladimirovich Chernyavsky, Associate Professor of the Department of Internal Medicine No. 1 of the National Medical University named after A.A. Bogomolets


Doctors of various specialties in their practice often encounter pathological conditions that, under certain conditions, can transform into serious diseases. These include biliary sludge, which should be considered as an early manifestation of cholelithiasis (GSD). Metabolic disorders, changes in the physicochemical properties of bile, an increase in its lithogenicity and a decrease in the contractile function of the gallbladder precede lithogenesis. Therefore, the therapeutic effect on these pathogenetic mechanisms makes it possible to prevent the development of HCS. This is extremely important, because the standard of care for the disease is cholecystectomy – an operative intervention that is second only to appendectomy in terms of frequency.

The main reason for the increase in the lithogenicity of bile is a change in the ratio of its components: cholesterol, bile acids and phospholipids. Excessive concentration of cholesterol in bile leads to its thickening, as a result of which crystals of cholesterol monohydrate are formed. Settling on the walls of the gallbladder, they create conditions for the occurrence of biliary sludge. It is known that stagnation of bile in the gallbladder, according to the feedback principle, inhibits choleresis, which is characterized by a decrease in the synthesis of bile solvents (lecithin, bile acids and their conjugates). This is accompanied by an increase in the lithogenicity of bile – and, as a result, the hypomotor gallbladder cannot remove the thick contents. Therefore, there is a close correlation between the bile lithogenicity index and hypokinetic dysfunction of the gallbladder. In the future, an inflammatory component joins the stagnation of bile, this leads to the fact that the pathological process passes into the initial stage of the housing and communal services – biliary sludge (from the English “sludge” – dirt, dregs). Despite the obvious pathogenetic relationship between the biliary tract and gastrointestinal tract, such a transformation occurs only in 8-23% of patients. After the elimination of the etiological factor (for example, in women after childbirth), spontaneous regression of the biliary flow is possible. However, this does not mean that such patients do not need medical treatment at all. If during an ultrasound examination (ultrasound) the patient has signs of biliary sloughing, timely preventive measures can prevent the development of complications.

As part of the scientific and practical conference with international participation “X Ukrainian Gastroenterological Week”, which took place on September 27-28 in the city of Dnipro, the Associate Professor of the Department tells in detail about the scientific and practical aspects of the treatment of biliary sludge and housing and communal services and methods for their correction in an actual interview with our correspondent internal medicine №1 National Medical University named after A.A. Bogomolets Vladimir Vladimirovich Chernyavsky.

Prepared by Ilona Tsyupa

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design